The Future of Pharmaceuticals: Insights from BullFrog AI's CEO

Oct. 24, 2023
Historically, only 12% of drugs that enter clinical trials make it to market. The average cost for a new drug is $2.6 billion, and it takes over eight years before a drug is ready to go to market. The top-15 pharma companies spent $100 billion on clinical research in 2018, and total R&D spending is expected to increase to $204 billion by 2024. Through its bfLEAP™ platform, BullFrog AI offers actionable insights at any stage of clinical development. With over 200 different algorithmic models, bfLEAP™ aims to identify high-value data and highly responsive patients for more efficient, successful clinical development of new therapeutics with the ultimate goal of ushering in a new era of precision medicine. Visit to learn more.

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market